New hope for young blood cancer patients: QUAIL-100 trial launches
Disease control
Not yet recruiting
This early-stage study tests a new drug, QUAIL-100, in 12 children and young adults with high-risk leukemia or myelodysplastic syndrome who have already received a special type of stem cell transplant. The main goal is to check the drug's safety and side effects. Participants wil…
Phase: PHASE1 • Sponsor: Laguna Biotherapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC